Home

Using antifibrinolytics in the peripartum period – concern for a hypercoagulable effect?

April 18th 2017 | H.K. Ahmadzia*, E.L. Lockhart , S.M. Thomas , I.J. Welsby , M.R. Hoffman , A.H. James, A.P. Murtha, G.K. Swamy, C.A. Grotegut

Abstract.
INTRODUCTION: Although antifibrinolytic agents are used to prevent and treat hemorrhage, there are concerns about a potential increased risk for peripartum venous thromboembolism. We sought to determine the impact of tranexamic acid and ɛ-aminocaproic acid on in vitro ...

Reviews

Hypocortisolism and preterm birth

Research

Using antifibrinolytics in the peripartum period – concern for a hypercoagulable effect?

Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss

Clinical Cases

Early onset necrotizing enterocolitis (NEC) in premature twins

Management of mixed type congenital mesoblastic nephroma: Case series and review of the literature

Subscribe to Front page feed